<DOC>
	<DOCNO>NCT01793610</DOCNO>
	<brief_summary>This small ( `` pilot '' ) study design provide information whether psychotherapy combine drug MDMA safe helpful people posttraumatic stress disorder ( PTSD ) . The researcher plan use result study design study . This study compare two dos MDMA active dose 1 , two dos MDMA active dose 2 , comparator-dose MDMA . There initial dose possibly follow one half two half hour later second dose half size first dose . The study measure symptom PTSD , depression , general psychological well-being sleep low dose versus active dos MDMA . Subjects experience pain tinnitus ( ring ear ) start study report level pain tinnitus study . The study also examine whether follow standardized treatment relate change PTSD symptom . Subjects prepare MDMA-assisted psychotherapy prior first session , work pair therapist two MDMA-assisted psychotherapy session , second session occur three five week first session . Symptoms PTSD , depression , general psychological well-being , feel world unreal ( dissociation ) , potential positive effect traumatic event sleep quality assess one month second MDMA-assisted session . Cognitive function measure one month second MDMA-assisted session . Participants receive comparator-dose MDMA enroll Stage 2 , wherein three MDMA-assisted psychotherapy session . People receive either active-dose MDMA third MDMA-assisted session . Cognitive function measure two month last Stage 1 Stage 2 MDMA-assisted session.Subject PTSD symptom , depression psychological symptom , symptom sleep two month final MDMA-assisted session least 12 month begin study .</brief_summary>
	<brief_title>Dose-Response Study MDMA-assisted Psychotherapy People With PTSD</brief_title>
	<detailed_description>Posttraumatic stress disorder ( PTSD ) debilitate disorder develop people experience traumatic event , rape , car accident life threaten event . PTSD worldwide health problem . PTSD treat psychotherapy drug , treatment help everyone . 3,4-methylenedioxymethamphetamine ( MDMA ) -assisted psychotherapy might potential treatment PTSD . MDMA active ingredient ecstasy . Before made illegal , psychotherapist combine MDMA psychotherapy help treat people psychological problem , include PTSD . This study randomize , double-blind dose-response study compare comparator-dose MDMA full-dose MDMA . The study drug give initial dose possibly follow 1.5 hour later second dose half size first dose . This Phase 2 pilot study examine safety efficacy MDMA-assisted psychotherapy 23 subject chronic , treatment-resistant PTSD least 6 month duration unable recover despite receive prior treatment either drug psychotherapy , discontinue treatment due lack tolerance treatment . Seven subject randomize full-dose MDMA five subject randomize comparator-dose MDMA . MDMA administer two experimental session last 8 hour schedule three five week apart . The study last one half year , include approximately three five month psychotherapy , long-term follow visit schedule year final experimental session . Study subject medical psychiatric examination make sure take part study . Once study , see male female psychotherapist entire study . The subject learn MDMA-assisted psychotherapy investigator learn subject three preparatory session occur first experimental session . During experimental session , subject receive initial dose either full comparator-dose MDMA along psychotherapy , one half two half hour later , subject may supplemental dose half size initial dose MDMA . Vital sign psychological distress measure throughout experimental session . There three integrative psychotherapy session experimental session , include one occur day experimental session . Subjects express , understand , bring together connect thought feeling symptom cause , discuss experience experimental session therapist . Subjects learn whether receive comparator full dose MDMA one month second experimental session . Subjects receive full-dose MDMA finish Stage 1 third experimental session , subject receive comparator-dose may go Stage 2 , open-label stage nearly identical stage 1 , one instead three preparatory session , experimental session one two active dos MDMA . Symptoms PTSD depression , sleep quality , general psychological well-being , dissociation posttraumatic growth ( potentially positive effect experience traumatic event ) measure subject baseline , one month second experimental session 12 month final experimental session . Cognitive function assess subject baseline one month second experimental session . Participant report pain tinnitus record symptom throughout study via visual analog scale . Subjects receive either Active Dose 1 Active Dose 2 go third experimental session complete questionnaire measure symptom PTSD depression , general psychological well-being , dissociation , sleep quality posttraumatic growth two month third experimental session . Depending upon condition assignment continuation Stage 2 , cognitive function assess two month third Stage 1 Stage 2 session . Subjects assign comparator-dose MDMA test one month second Stage 2 experimental session two month third experimental session . People also complete measure experience experimental session soon experimental session . This study compare effect MDMA-assisted psychotherapy comparator versus full-dose MDMA , also assess duration change symptoms year MDMA-assisted psychotherapy .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>N-Methyl-3,4-methylenedioxyamphetamine</mesh_term>
	<criteria>Diagnosed chronic PTSD six month longer Have CAPS score show moderate severe PTSD symptom At least one unsuccessful attempt treatment PTSD either talk therapy drug , discontinue treatment inability tolerate psychotherapy drug therapy . Are least 18 year old Must generally healthy Are willing refrain take psychiatric medication study period Willing follow restriction guideline concern consumption food , beverage nicotine night prior MDMA session . Willing remain overnight study site ; Agree transportation drive home stay integrative session day MDMA session Are willing contacted via telephone necessary telephone contact Must negative pregnancy test able bear child , agree use effective form birth control Must provide contact event subject become suicidal Agree let investigator know within 48 hour plan medical intervention ; Are proficient read speak English Agree psychotherapy session record audio/video Agree participant interventional clinical trial course study Are pregnant nursing , woman child , practice effective mean birth control Weigh le 48 kg Are abuse illegal drug Are unable give adequate inform consent Upon review past current drugs/medication must take medication exclusionary . Upon review medical psychiatric history must current past diagnosis would consider risk participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>MDMA</keyword>
	<keyword>Posttraumatic stress disorder</keyword>
	<keyword>sleep</keyword>
	<keyword>Depression</keyword>
	<keyword>Safety</keyword>
</DOC>